Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group of diabetes drugs called sulfonylureas, finds a study from South Korea published in The BMJ.
source https://medicalxpress.com/news/2025-10-sglt-diabetes-drugs-linked-autoimmune.html
source https://medicalxpress.com/news/2025-10-sglt-diabetes-drugs-linked-autoimmune.html
Comments
Post a Comment